Assessment of a balloon-tipped catheter modified for intracerebral convection-enhanced delivery

Journal of Neuro-Oncology

Volumn 89, Issue 2, 2008, Pages 159-168

  Olson, Jeffrey J ^a   Zhang, Zhaobin ^a   Dillehay, Dirk ^a   Stubbs, James ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Cytyc Corporation   (United States)

Author keywords

Animal; Brain neoplasm; Convection; Disease models; Drug delivery systems; Gadolinium; Glioma

Indexed keywords

CARMUSTINE; GADOLINIUM PENTETATE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BALLOON CATHETER; BOLUS INJECTION; BRAIN TUMOR; CONTINUOUS INFUSION; CONTROLLED STUDY; DEVICE; DOG; DRUG DELIVERY SYSTEM; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG INFUSION; FEASIBILITY STUDY; INTERMETHOD COMPARISON; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; THERMODYNAMICS;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CARMUSTINE; CATHETERIZATION; CONVECTION; DOGS; DRUG DELIVERY SYSTEMS; GADOLINIUM; INFUSIONS, INTRALESIONAL; MAGNETIC RESONANCE IMAGING; MALE; TIME FACTORS;

EID: 48749114405     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-008-9612-7     Document Type: Article

References (22)

1. Uhm JH, Dooley NP, Villemure JG et al (1997) Mechanisms of glioma invasion: Role of matrix-metalloproteinases. Can J Neurol Sci 24:3-15
2. Preusser M, Haberler C et al (2006) Malignant glioma: Neuropathology and neurobiology. Wien Med Wochenschr 156:332-337
3. Mawrin C (2005) Molecular genetic alterations in gliomatosis cerebri: what can we learn about the origin and course of the disease? Acta Neuropathol 110:527-536
4. Pardridge WM (1998) CNS drug design based on principles of blood-brain barrier transport. J Neurochem 70:1781-1792
5. Engelhard HH (1998) Antisense oligodeoxynucleotide technology: Potential use for the treatment of malignant brain tumors. Cancer Control 5:163-170
6. Groothuis DR (2000) The blood-brain and blood-tumor barriers: A review of strategies for increasing drug delivery. Neuro-Oncology 2:45-59
7. Bouvier G, Penn RD et al (1987) Direct delivery of medication into a brain tumor through multiple chronically implanted catheters. Neurosurgery 20:286-291
8. Walter KA, Tamargo RJ et al (1995) Intratumoral chemotherapy. Neurosurgery 37:1129-1145
9. Newton HB (2006) Advances in strategies to improve drug delivery to brain tumors. Expert Rev Neurother 6:1495-1509
10. Bobo R, Laske D et al (1994) Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci USA 91:2076-2080
11. Morrison PF, Chen MY et al (1999) Focal delivery during direct infusion to brain: Role of flow rate, catheter diameter, and tissue mechanics. Am J Physiol 277:R1218-R1229
12. Chen MY, Lonser RR et al (1999) Variables affecting convection-enhanced delivery to the striatum: A systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time. J Neurosurg 90:315-320
13. Raghavan R, Brady ML et al (2006) Convection-enhanced delivery of therapeutics for brain disease, and its optimization: Neurosurgical focus. 20:E12. http://www.aans.org/education/journal/neurosurgical/Apr06/ 20-4-nsf-toc.asp
14. Lopez KA, Waziri AE et al (2006) Convection-enhanced delivery in the treatment of malignant glioma. Neurol Res 28(5):542-548
15. Lieberman D, Laske K et al (1995) Convection-enhanced distribution of large molecules in gray matter during interstitial drug infusion. J Neurosurg 82:1021-1029
16. Laske DW, Morrison PF et al (1997) Chronic interstitial infusion of protein to primate brain: Determination of drug distribution and clearance with single-photon emission computerized tomography imaging. J Neurosurg 87:586-594
17. Laske DW, Youle RJ, Oldfield EH (1997) Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors. Nat Med 3:1362-1368
18. Tatter SB, Shaw EG et al (2003) An inflatable balloon catheter and liquid 125I radiation source (GliaSite Radiation Therapy System) for treatment of recurrent glioma: Multicenter and feasibility study. J Neurosurg 99:297-303
19. Stubbs JB, Strickland AD et al (2000) Biodistribution and dosimetry of an aqueous solution containing sodium 3-(125I) iodo-4-hydroxybenzenesulfonate (Iotrex) for brachytherapy of resected malignant brain tumors. Cancer Biother Radiopharm 15:645-656
20. Gabayan AJ, Green SB et al (2006) GliaSite brachytherapy for treatment of recurrent malignant gliomas: A retrospective multi-institutional analysis. Neurosurgery 58:701-709
21. Stubbs JB, Frankel RH et al (2002) Preclinical evaluation of a novel device for delivering brachytherapy to the margins of resected brain tumor cavities. J Neurosurg 9:335-343
22. Garfield J, Dayan AD et al (1975) Postoperative intracavitary chemotherapy of malignant supratentorial astrocytomas using BCNU. Clin Oncol 1:213-222